Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

284
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
284
Study Design in Statistics01:15

Study Design in Statistics

9.8K
A study design is a set of techniques that allow a researcher to collect and analyze data from different variables defined for a specific research problem. Statistics is commonly for effective study design and more robust experiments,
Does aspirin reduce the risk of heart attacks? Is one brand of fertilizer more effective at growing roses than another? Is fatigue as dangerous to a driver as the influence of alcohol? Questions like these are answered using randomized experiments with proper...
9.8K
Clinical Trials01:16

Clinical Trials

10.0K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
10.0K
Statistical Software for Data Analysis and Clinical Trials01:12

Statistical Software for Data Analysis and Clinical Trials

1.2K
Statistical software is pivotal in data analysis and clinical trials by providing tools to analyze data, draw conclusions, and make predictions. These software packages range from simple data management applications to complex analytical platforms, supporting various statistical tests, models, and simulation techniques. Their significance lies in their ability to handle vast amounts of data with precision and efficiency, enabling researchers to validate hypotheses, identify trends, and make...
1.2K
Study Designs in Epidemiology01:20

Study Designs in Epidemiology

693
Epidemiological study designs are fundamental tools for investigating the distribution, determinants, and control of health conditions in populations. They help researchers understand the relationships between exposures and outcomes, and they broadly fall into two categories: "observational" and "experimental" studies.
Observational studies are those where the researcher does not intervene but rather observes natural variations. They include cross-sectional, cohort, and...
693
Clinical Trials: Overview01:11

Clinical Trials: Overview

4.4K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
4.4K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Evaluation of the Clinical Effectiveness and Cost-Effectiveness of Tirzepatide for Type 2 Diabetes in Canada Using Bayesian Transportability Analysis.

Value in health regional issues·2026
Same author

Clinical trial priorities, adaptive strategies, and equitable partnerships for the Bundibugyo Ebola outbreak.

The Lancet. Infectious diseases·2026
Same author

Anchoring convenience survey samples to a baseline census for vaccine coverage monitoring in global health.

Vaccine·2026
Same author

Ebola outbreak caused by Bundibugyo virus: challenges and priorities for epidemic preparedness and response.

Lancet (London, England)·2026
Same author

Logistical Challenges in Platform Randomized Trials - Operational Realities That Curb the Promise of Efficiency.

Clinical epidemiology·2026
Same author

Platform Trial Barriers-Why We Are Returning to Old Ways.

JAMA network open·2026
Same journal

Impact of Information Leakage in Platform Trials With Survival Endpoints on Type I Error Control.

Pharmaceutical statistics·2026
Same journal

Harmonic Fowlkes-Mallows Index for Medical Diagnostics Tests and Optimal Cut-Off Point Selection of Binary Diseases.

Pharmaceutical statistics·2026
Same journal

Early Phase Dose-Finding Designs for CAR-T Cell Therapies.

Pharmaceutical statistics·2026
Same journal

Optimizing Randomization Ratios in Clinical Trials With Survival Endpoints.

Pharmaceutical statistics·2026
Same journal

CUI-MET: A Clinical Utility Index Based Analysis and Decision Framework for Dose Optimization in Multiple-Dose, Multiple-Outcome Randomized Trials.

Pharmaceutical statistics·2026
Same journal

Will the Pharmaceutical Industry Need Statisticians in an AI World?

Pharmaceutical statistics·2026
See all related articles

Related Experiment Video

Updated: Dec 4, 2025

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index
06:55

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index

Published on: January 8, 2020

14.9K

Utilizing Bayesian predictive power in clinical trial design.

Ofir Harari1, Grace Hsu1, Louis Dron1

  • 1Real World and Advanced Analytics, Cytel Canada, Vancouver, British Columbia, Canada.

Pharmaceutical Statistics
|October 22, 2020
PubMed
Summary
This summary is machine-generated.

Bayesian predictive power (BPP) quantifies clinical trial success probability. This study provides accessible mathematical expressions for BPP, aiding adaptive trial design and futility monitoring.

Keywords:
Bayesian predictive powerclinical trialssample size

More Related Videos

An R-Based Landscape Validation of a Competing Risk Model
05:37

An R-Based Landscape Validation of a Competing Risk Model

Published on: September 16, 2022

2.4K
Identification of Disease-related Spatial Covariance Patterns using Neuroimaging Data
14:27

Identification of Disease-related Spatial Covariance Patterns using Neuroimaging Data

Published on: June 26, 2013

16.0K

Related Experiment Videos

Last Updated: Dec 4, 2025

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index
06:55

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index

Published on: January 8, 2020

14.9K
An R-Based Landscape Validation of a Competing Risk Model
05:37

An R-Based Landscape Validation of a Competing Risk Model

Published on: September 16, 2022

2.4K
Identification of Disease-related Spatial Covariance Patterns using Neuroimaging Data
14:27

Identification of Disease-related Spatial Covariance Patterns using Neuroimaging Data

Published on: June 26, 2013

16.0K

Area of Science:

  • Biostatistics
  • Clinical Trial Design
  • Decision Science

Background:

  • The Bayesian paradigm offers a robust framework for updating uncertainties with new data.
  • Bayesian predictive power (BPP) is a key metric reflecting confidence in a clinical trial's success.
  • Current BPP calculations can be complex, limiting widespread adoption in adaptive trial design.

Purpose of the Study:

  • To derive accessible mathematical expressions for Bayesian predictive power (BPP) across common clinical trial outcome types.
  • To enhance the practical application of BPP in adaptive trial design and interim futility monitoring.
  • To propose a structured framework for phase II-to-phase III clinical trial progression based on BPP.

Main Methods:

  • Derivation of mathematical formulas for BPP for standard clinical trial endpoints.
  • Integration of BPP calculations into simulation frameworks for adaptive trial designs.
  • Development of a BPP-guided decision-making process for transitioning between clinical trial phases.

Main Results:

  • Novel mathematical expressions for BPP are presented, simplifying its computation.
  • The derived BPP formulas facilitate rapid simulations for adaptive trial designs, including futility monitoring.
  • An organized BPP-based framework for phase II-to-phase III clinical trial progression is proposed.

Conclusions:

  • Accessible BPP calculations empower practitioners to better assess clinical trial success probabilities.
  • The proposed methods and framework support more efficient and informed adaptive clinical trial designs.
  • This work bridges the gap between Bayesian theory and practical clinical trial decision-making.